FRANKLIN
LAKES, N.J., March 27,
2025 /PRNewswire/ -- BD (Becton, Dickinson and
Company) (NYSE: BDX), a leading global medical technology company,
today announced the appointment of Gregory J. Hayes to its
board of directors, effective March 26,
2025.
Hayes, 64, is currently the executive chairman of the board of
directors of RTX Corporation, the world's largest aerospace and
defense company. He brings more than 30 years of extensive
executive experience, having held chief executive officer and
senior leadership roles across finance, corporate strategy and
business development functions, as well as leadership of large and
complex businesses undergoing transformative initiatives, including
M&A and spinoff transactions. Hayes' appointment to the BD
board of directors is in line with the company's ongoing commitment
to strong corporate governance and regular board refreshment. With
this appointment, the BD board of directors has added four new,
independent directors since 2021.
"Greg will join the board at a pivotal time in BD's
transformation, as we seek to unlock significant shareholder value
through the planned separation of our Diagnostic Solutions and
Biosciences business and launch of the 'New BD' as a medtech leader
representing the foundation and future of health care," said
Tom Polen, chairman, CEO and
president of BD. "Greg's proven track record of portfolio
optimization, strategic excellence and driving operational
efficiency is well aligned with the BD Excellence operating system
and our deep commitment to a culture of continuous improvement. He
will be an invaluable asset to our board of directors and the
future success of BD."
Prior to his appointment to the RTX board of directors, Hayes'
career at United Technologies Corporation (UTC) spanned two
decades, culminating in his appointment to chief executive officer
in 2014 and chairman in 2016. As CEO, Hayes was instrumental in the
formation of RTX — the result of the 2020 merger of UTC's aerospace
businesses, Pratt & Whitney and Collins Aerospace, with
Raytheon Company. Hayes, who joined UTC in 1999 through its merger
with the Sundstrand Corporation, also served as UTC's chief
financial officer from 2008 to 2014. He also serves on the board of
directors for Phillips 66 Company.
"BD has a remarkable 125-year history as a leading manufacturer
of medical devices and is critical to the infrastructure of our
health care system," said Hayes. "We have an incredible opportunity
ahead, and I look forward to leveraging my experience to help
oversee a successful separation and establish 'New BD' as a
differentiated and focused pure-play medtech company that is
positioned to accelerate innovation, drive profitable growth and
deliver long-term sustainable value for all stakeholders."
Hayes earned a bachelor's degree in Economics from Purdue University and is a certified public
accountant.
About BD
BD is one of the largest global medical technology companies in the
world and is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. The company
supports the heroes on the frontlines of health care by developing
innovative technology, services and solutions that help advance
both clinical therapy for patients and clinical process for health
care providers. BD and its more than 70,000 employees have a
passion and commitment to help enhance the safety and efficiency of
clinicians' care delivery process, enable laboratory scientists to
accurately detect disease and advance researchers' capabilities to
develop the next generation of diagnostics and therapeutics.
BD has a presence in virtually every country and partners with
organizations around the world to address some of the most
challenging global health issues. By working in close collaboration
with customers, BD can help enhance outcomes, lower costs, increase
efficiencies, improve safety and expand access to health care. For
more information on BD, please visit bd.com or connect
with us on LinkedIn at www.linkedin.com/company/bd1/, X
(formerly Twitter) @BDandCo or
Instagram @becton_dickinson.
Contacts:
|
|
Media:
|
Investors:
|
Troy Kirkpatrick
|
Adam Reiffe
|
VP, Public
Relations
|
Senior Director,
Investor Relations
|
858.617.2361
|
201.847.6927
|
troy.kirkpatrick@bd.com
|
adam.reiffe@bd.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bd-names-gregory-j-hayes-to-board-of-directors-302412390.html
SOURCE BD (Becton, Dickinson and Company)